Key Takeaways
- CRWV shares plummeted over 11% following first quarter financial results that disappointed investors
- The company recorded a loss of $1.40 per share, significantly worse than analyst projections of -$0.92
- Quarterly revenue exceeded expectations at $2.08 billion, representing 127% growth compared to the prior year
- Major stakeholder Magnetar Financial offloaded $370.5 million in CRWV shares immediately following the earnings announcement
- Over the past three months, company insiders have collectively sold approximately $1.9 billion in stock, resulting in a “Negative” insider trading assessment
Shares of CoreWeave experienced a sharp decline of more than 11% during after-hours trading on May 8 following the release of first quarter 2026 financial results that disappointed on profitability metrics.
CoreWeave, Inc. Class A Common Stock, CRWV
The shares were changing hands near $114 in the wake of the decline, retreating from levels above $129 seen earlier in the week.
For the first quarter of 2026, CoreWeave posted a per-share loss of $1.40. Analysts surveyed by Wall Street had been anticipating a more modest loss of $0.92 per share. The variance proved difficult for the market to overlook.
Management also provided conservative projections for the remainder of the fiscal year, citing escalating infrastructure expenses and intensifying rivalry in the artificial intelligence cloud computing sector.
On the top line, however, the picture looked brighter. CoreWeave generated $2.08 billion in quarterly revenue, marking a 127% surge from the same period last year. This figure surpassed Wall Street’s consensus forecast of $1.97 billion.
The organization additionally disclosed that its revenue backlog increased and that it surpassed one gigawatt of total active power capacity during the reporting period.
DA Davidson maintained its Buy recommendation on CRWV following the release, establishing a $175 price objective. The investment firm sustained its optimistic outlook notwithstanding the profitability shortfall.
Major Shareholder Exits $370 Million Position Following Results
As market participants processed the earnings disappointment, CoreWeave’s primary insider was actively divesting holdings.
Magnetar Financial LLC, which controls more than 10% of CoreWeave‘s outstanding shares, completed four distinct sale transactions on May 8, coinciding with the earnings release.
The investment firm disposed of more than 2.7 million shares at prices ranging from $129 to $139, generating total proceeds of $370.45 million.
An additional regulatory filing revealed that Magnetar-affiliated entities also divested 157,368 shares on May 7 at prices spanning $129.73 to $133.00, totaling approximately $20.7 million.
These transactions were executed across multiple Magnetar Funds, with Magnetar Financial LLC acting as the investment adviser.
Three-Month Insider Disposal Reaches $1.9 Billion
The May 8 divestiture represents just one component of a broader selling pattern. Throughout the preceding three months, company insiders have collectively disposed of $1.9 billion worth of CRWV shares.
This substantial selling volume has resulted in CoreWeave receiving a “Negative” insider activity classification on TipRanks.
While executives divest shares for numerous legitimate reasons that don’t necessarily indicate underlying business concerns, the magnitude of these sales has attracted scrutiny given the stock’s strong previous performance.
Prior to the post-earnings decline, CRWV had appreciated 59% year-to-date and had climbed approximately 95% over the trailing twelve-month period.
InvestingPro analysis suggests that CoreWeave trades above its Fair Value estimate at present price levels.
According to TipRanks data, CRWV maintains a Moderate Buy consensus among analysts, derived from 14 Buy recommendations, nine Hold ratings, and one Sell rating. The average analyst price target stands at $133.70, suggesting approximately 17% potential appreciation from current trading levels.
The latest analyst commentary originated from DA Davidson, which reaffirmed its Buy stance with a $175 price objective subsequent to the Q1 disclosure.
